Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Osteosarcoma as a second malignant neoplasm in children.

J R Bechler1, W W Robertson, A T Meadows

  • 1Division of Orthopaedic Surgery, Children's Hospital of Philadelphia, University of Pennsylvania School of Medicine 19114.

The Journal of Bone and Joint Surgery. American Volume
|August 11, 1992
PubMed
Summary

Secondary osteosarcoma is an increasing risk for childhood cancer survivors treated with radiation. This often fatal complication necessitates careful consideration in long-term treatment planning.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development of curative therapies for Ewing sarcomas by interdisciplinary cooperative groups in Europe.

Klinische Padiatrie·2015
Same author

Pathways Linking Treatment Intensity and Psychosocial Outcomes among Adult Survivors of Childhood Leukemia.

Journal of health psychology·2011
Same author

Second cancers following Hodgkin's lymphoma: radiation therapy once more.

Annals of oncology : official journal of the European Society for Medical Oncology·2011
Same author

Predicting cisplatin ototoxicity in children: the influence of age and the cumulative dose.

European journal of cancer (Oxford, England : 1990)·2004
Same author

Long-term follow-up of short intensive multiagent chemotherapy without high-dose methotrexate ('Orange') in children with advanced non-lymphoblastic non-Hodgkin's lymphoma: a children's cancer group report.

Leukemia·2002
Same author

Rhabdomyosarcoma of the parotid region occurring in childhood and adolescence. A report from the Intergroup Rhabdomyosarcoma Study Group.

Cancer·2001

Area of Science:

  • Pediatric Oncology
  • Radiation Oncology
  • Cancer Survivorship

Background:

  • Osteosarcoma as a second malignant neoplasm (SMN) is a rare but serious complication.
  • Children treated for primary malignancies with radiation therapy are at risk for developing SMN.
  • Understanding the incidence and outcomes of radiation-induced osteosarcoma is crucial for pediatric cancer care.

Observation:

  • Nine pediatric patients with secondary osteosarcoma in previously irradiated sites were analyzed.
  • Primary diagnoses included Ewing sarcoma, Wilms tumor, and Hodgkin lymphoma, among others.
  • Average radiation dose was 4144 cGy, with a median latency of over 10 years from initial treatment.

Findings:

  • Three of nine patients survived, two with active disease.

Related Experiment Videos

  • Six patients died within three years of secondary osteosarcoma diagnosis.
  • The prognosis for secondary osteosarcoma following childhood cancer treatment is poor.

    • Implications:

    • The rising survival rates in pediatric oncology increase the prevalence of secondary osteosarcomas.
    • Therapeutic strategies for primary childhood cancers must incorporate the long-term risk of radiation-induced SMN.
    • Further research into risk mitigation and early detection of secondary osteosarcomas is warranted.